Prognostic implications of cyclin B1, p34cdc2, p27Kip1 and p53 expression in gastric cancer

Yonsei Medical Journal

Volumn 48, Issue 4, 2007, Pages 694-700

  Kim, Dong Hoon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Cyclin B1; Gastric cancer; p27Kip1; p34cdc2; p53

Indexed keywords

CYCLIN B1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PROGNOSIS; PROTEIN INTERACTION; STOMACH CANCER;

ADULT; AGED; CDC2 PROTEIN KINASE; CYCLIN B; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34848926085     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.4.694     Document Type: Article

References (22)

1. Hunter T, Pines J. Cyclins and cancer. Cell 1991;66: 1071-4.
2. Nurse P. Ordering S phase and M phase in the cell cycle. Cell 1994;79;547-50.
3. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995;9:1149-63.
4. Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994;266:1821-8.
5. Ohta T, Okamoto K, Isohashi F, Shibata K, Fukuda M, Yamaguchi S, et al. T-loop deletion of CDC2 from breast cancer tissues eliminates binding to cyclin B1 and cyclin-dependent kinase inhibitor p2l. Cancer Res 1998;58:1095-8.
6. Nakayama K, Nakayama K. Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 1998;29:1020-9.
7. Kip1 protein:, prognostic implications in primary breast cancer. Nat Med 1997; 3:227-30.
8. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994;84:2412-21.
9. American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th ed. New York.- Springer-Verlag; 2002. p.99-103.
10. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, et al. p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies. Blood 1994;84:3148-57.
11. Pines J, Hunter T. Homan cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 1990;346:760-3.
12. Murakami H, Furibata M, Ohtsuki Y, Ogoshi S. Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 1999;434:153-8.
13. Soria JC, Jang SJ, Khuri FR, Hassap K, Liu D, Hong WK, et al. Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res. 2000;60:4000-4.
14. Ito Y, Takeda T, Sakon M, Monden M, Tsujimoto M, Matsuura N. Expression and prognostic role of cyclin-dependent kinase 1(cdc2) in hepatocellular carcinoma. Oncology 2000;59:68-74.
15. Park YJ, Wen J, Bang S, Park SW, Song SY. [6]-Gingerol induces cell cycle arrest and cell death of mutant p53-expressing pancreatic cancer cells. Yonsei Med J 2006;47.688-97.
16. Jeong J, Park YN, Park JS, Yoon DS, Chi HS, Kim BR. Clinical significance of p16 protein expression loss and aberrant p53 protein expression in pancreatic cancer. Yonsei Med J 2005;46:519-25.
17. Kip1 over-expression indicates a low-grade carcinoma profile. Histopathology 2000;38:454-7.
18. Baker SJ, Fearon ER, Nigro JM, Hamiltort-SR, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244:217-21.
19. Shaw PH. The role of p53 in cell cycle regulation. Pathol Res Pract 1996;192:669-75.
20. Vogelstein B, Kinzler KW. p53 function and dysfunction. Cell 1992;70:523-6.
21. Kip1 expression and clinicopathologic features in hepatocellular carcinoma. J Korean Cancer Assoc 2000; 32:390-7.
22. Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene l997;l4:2283-9.